1. A phase 1 dose‐escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma. Issue 21 (19th July 2016) Authors: Chari, Ajai; Htut, Myo; Zonder, Jeffrey A.; Fay, Joseph W.; Jakubowiak, Andrzej J.; Levy, Joan B.; Lau, Kenneth; Burt, Steven M.; Tunquist, Brian J.; Hilder, Brandi W.; Rush, Selena A.; Walker, Duncan H.; Ptaszynski, Mieke; Kaufman, Jonathan L. Journal: Cancer Issue: Volume 122:Issue 21(2016) Page Start: 3327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗